Interleukin-2 therapy: needs of the patient in a critical care setting

Critical Care Nurse
|December 1, 1994
PubMed

Insights

Interleukin-2 (IL-2) is an investigational biotherapeutic for advanced cancers. Critical care nurses manage its dose-related toxicities, addressing patients

Area of Science:

  • Immunology
  • Oncology
  • Critical Care Nursing

Background:

  • Interleukin-2 (IL-2) is a biological response modifier investigated as a biotherapeutic agent.
  • IL-2 is not FDA-approved for general use and is currently in clinical trials.
  • It is considered for advanced carcinoma patients refractory to standard treatments.

Purpose of the Study:

  • To highlight the role of critical care nurses in managing patients undergoing IL-2 therapy.
  • To emphasize the assessment and documentation of IL-2-related side effects.
  • To underscore the importance of addressing patients' physical and psychological needs during IL-2 treatment.

Main Methods:

  • Review of IL-2 therapy protocols and associated toxicities.
  • Focus on critical care nursing interventions for managing side effects.
  • Assessment of patient's physical and psychological status during IL-2 administration.

Main Results:

  • IL-2 administration can cause dose-related systemic toxicity requiring intensive care.
  • Critical care nurses play a vital role in monitoring and managing these toxicities.
  • Successful management involves addressing both physical and psychological patient needs.

Conclusions:

  • Critical care nurses require specific knowledge to manage IL-2 therapy effectively.
  • Comprehensive assessment and intervention are key to patient care.
  • Nurses are essential in optimizing patient outcomes during this intensive therapy.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Endotracheal Intubation II: Nursing Management01:17

Endotracheal Intubation II: Nursing Management

Endotracheal intubation is a critical procedure that can be lifesaving for many patients with respiratory distress or failure. The role of nursing in managing endotracheal tubes is pivotal, as it involves pre-intubation preparation, assisting during the procedure, and post-extubation care.
1. Nursing Care of Patients Before Intubation
Before the endotracheal intubation procedure, nurses play an essential role in ensuring the process goes smoothly. The nurses must be familiar with intubation...